• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, July 4, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Non-invasive brain stimulation improves gait impairment of Parkinson’s disease patients

Bioengineer by Bioengineer
March 8, 2018
in Health
Reading Time: 3 mins read
1
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Walking presents many challenges for patients with Parkinson's disease. Among the most burdensome of these challenges is "freezing of gait," the sudden onset of immobility mid-step. It often causes falls and leads to a reduction in quality of life.

A new Tel Aviv University study suggests a novel way of treating the affected areas of the brain that apparently cause freezing of gait. It proposes that transcranial direct-current electrical stimulation of the primary motor cortex and the left dorsolateral prefrontal cortex significantly ameliorates the condition.

"The effects of multi-target simultaneous stimulation of motor and cognitive networks demand investigation," says Prof. Jeffrey Hausdorff of TAU's Sackler School of Medicine and the Center for Movement Disorders at Tel Aviv Medical Center, who led the research for the study, just published in the journal Movement Disorders.

Research for the study was also conducted by TAU neuroscience doctoral student Moria Dagan; Prof. Nir Giladi of TAU's Sackler School of Medicine and Tel Aviv Medical Center; Dr. Tali Herman of Tel Aviv Medical Center; and a team of researchers from Harvard Medical School led by Dr. Brad Manor and Prof. Lew Lipsitz.

Real and "sham" stimulation examined

The team of scientists examined 20 Parkinson's disease patients, who often experience freezing of gait. The patients received 20 minutes of transcranial direct current stimulation via a cap that the subjects wore on their head on three separate visits. Transcranial direct current stimulation targeted the primary motor cortex and left dorsolateral prefrontal cortex simultaneously; the primary motor cortex only; or underwent "sham," placebo stimulation, where the subject feels some tingling sensation, but the amount of stimulation is negligible.

Before and after each round of stimulation, the participants completed a test that provoked freezing of gait, a static and dynamic mobility test (known as "Timed Up and Go"), gait assessment, and a cognitive test for processing speed, selective attention and inhibition control (Stroop test).

"What we found was quite encouraging," says Prof. Hausdorff. "The participants' walking improved after simultaneous stimulation of the primary motor cortex and left dorsolateral prefrontal cortex, but not after primary motor cortex only or sham stimulation. The results of the study reveal that transcranial direct current stimulation designed to simultaneously target motor and cognitive regions apparently induces immediate aftereffects in the brain that translate into reduced freezing of gait and improvements in executive function and mobility."

Multi-site stimulation most effective

After 20 minutes of multi-site stimulation, the patients' freezing of gait was reduced and mobility and cognition improved — more than that seen after stimulation of primary motor cortex only or through sham simulation.

"In other words, a larger, more positive effect is obtained when both motor and cognitive areas are targeted," Prof. Hausdorff concludes. "When thinking about treatments for freezing of gait, it is important to target both motor and cognitive functions.

"Even among patients with advanced Parkinson's disease and freezing of gait, it is apparently possible to improve brain function via non-invasive brain stimulation, at least in the short-term, and this has positive, functional consequences."

Together with their collaborators at Harvard Medical School, the TAU-TAMC team is currently conducting a randomized controlled trial to determine the long-term benefits of this multi-site stimulation on freezing of gait and related symptoms.

###

American Friends of Tel Aviv University (AFTAU) supports Israel's most influential, comprehensive and sought-after center of higher learning, Tel Aviv University (TAU). TAU is recognized and celebrated internationally for creating an innovative, entrepreneurial culture on campus that generates inventions, startups and economic development in Israel. For three years in a row, TAU ranked 9th in the world, and first in Israel, for alumni going on to become successful entrepreneurs backed by significant venture capital, a ranking that surpassed several Ivy League universities. To date, 2,400 patents have been filed out of the University, making TAU 29th in the world for patents among academic institutions.

Media Contact

George Hunka
[email protected]
212-742-9070
@AFTAUnews

Home

https://www.aftau.org/weblog-medicine–health?&storyid4704=2383&ncs4704=3

Related Journal Article

http://dx.doi.org/10.1002/mds.27300

Share12Tweet7Share2ShareShareShare1

Related Posts

Lysine Pyruvylation Links Glycolysis to Epigenetics

July 4, 2026

Personalized Neoantigen Dendritic Cell Vaccine in Glioblastoma

July 4, 2026

Decoding Neural Timescales: A Computational Viewpoint

July 4, 2026

Uncovering C5aR2: Unique Signaling and Agonists

July 4, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Quasi-Bound States Boost Quantum Well Photoresponse

Lysine Pyruvylation Links Glycolysis to Epigenetics

Multiphysics Coupling: Single vs. Multiple DeepONet Branches

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.